Scancell Holdings Share News (SCLP)

Scancell Holdings Information

Buy SCLP Shares
Add SCLP to Watchlist
Add SCLP to Alert

Share Price Information for Scancell Holdings (SCLP)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 10.10

Bid: 9.70

Ask: 10.50

Change: 0.00 (0.00%)

Spread: 0.80 (8.247%)

Open: 10.10

High: 10.10

Low: 10.10

Prev. Close: 10.10

Last checked at -

UK Earnings, Trading Statements Calendar - Next 7 Days

Tue, 13th Aug 2019 15:58

Wednesday 14 August
Avast	Half Year Results
Lookers	Half Year Results
Balfour Beatty	Half Year Results
Admiral Group	Half Year Results
Prudential	Half Year Results (at 0930 BST)
Apax Global Alpha	Half Year Results
CLS Holdings	Half Year Results
Hochschild Mining	Half Year Results
Georgia Healthcare Group	Half Year Results
Bank of Georgia	Half Year Results
Riverstone Energy	Half Year Results
JPMorgan American Investment Trust	Half Year Results
Thursday 15 August
TBC Bank	Half Year Results
GVC Holdings	Half Year Results
Marshalls	Half Year Results
KAZ Minerals	Half Year Results
Gem Diamonds	Trading Statement
Friday 16 August
no events scheduled
Monday 19 August
BATM Advanced Communications	Half Year Results
Tuesday 20 August
BHP Group	Full Year Results
John Wood Group	Half Year Results
Finablr	Half Year Results
Persimmon	Half Year Results
Scancell Holdings	Half Year Results
Tribal Group	Half Year Results
Empiric Student Property	Half Year Results
Hostelworld	Half Year Results
Global Ports Holdings	Half Year Results
Kenmare Resources	Half Year Results

More News

10 Oct 2014 14:48

UK AGM, EGM Calendar - Week Ahead

10 Oct 2014 05:26

UK AGM, EGM Calendar - Week Ahead

9 Oct 2014 15:15

UK AGM, EGM Calendar - Week Ahead

9 Oct 2014 05:26

UK AGM, EGM Calendar - Week Ahead

8 Oct 2014 14:58

UK AGM, EGM Calendar - Week Ahead

8 Oct 2014 05:26

UK AGM, EGM Calendar - Week Ahead

7 Oct 2014 15:05

UK AGM, EGM Calendar - Week Ahead

4 Sep 2014 11:23

Scancell Holdings sees annual losses widen

Scancell Holdings, a developer of novel immunotherapies for the treatment of cancer, made an annual loss of £2.22m in the year to 30 April compared to £1.9m last year. The company development spending increased due to additional costs in pre-clinical studies for a new platform technology, while adm

4 Sep 2014 09:36

Scancell Full-Year Loss Widens On Development, Administrative Costs

12 Aug 2014 11:14

UK MIDDAY BRIEFING: Serco CEO Bolsters Top Team Again

12 Aug 2014 11:03

UK WINNERS & LOSERS: Just Eat Delivers Tasty Revenue Growth

12 Aug 2014 08:12

Scancell Boosted By Positive Results SCIB1, PD-1 Combination

12 Aug 2014 07:35

UK MORNING BRIEFING: Just Eat Leads Mixed Market On Mobile Sales

6 Jun 2014 08:54

Scancell Holdings ImmunoBody technology receives US approval

AIM-listed Pharmaceuticals group Scancell Holdings announced a patent for its DNA ImmunoBody technology has been approved in the US. The patent has been granted by the United States Patent and Trademark Office (USPTO) and covers Scancell's DNA ImmunoBody platform technology. This patent is expect

6 Jun 2014 08:52

Scancell Granted US Patent For DNA Immunobody Technology

LONDON (Alliance News) - Scancell Holdings PLC said Friday its DNA Immunobody technology platform had been granted a patent by the US Patent and Trademark Office. Scancell said the patent was key for the protection of its pipeline of vaccines utilising the technology. It has already been gr

Latest Share Chat

Scancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Login to your account

Quickpicks are a member only feature

Login to your account